GT Biopharma (NASDAQ:GTBP) just reported results for the first quarter of 2024.
- GT Biopharma reported earnings per share of -$1.64. This was above the analyst estimate for EPS of -$2.70.
- The company did not report any revenue for the quarter.
Please enter the email address associated with your account and we'll send you a magic link for a password-free sign in.
The provided email address must be associated with an account to receive a login link. If you can't find the email, please check your spam folder.
Enter your existing account details once to link them to this sign-in method.
Not Yet a Premium Subscriber?
Subscribe